Cash Flow

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Aug. 31, 2016
Aug. 31, 2015
Cash Flows from Operating Activities:    
Net loss $ (674,155) $ (1,506,480)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest income-amortization of original issue discount (73,086)
Interest expense on warrant issuance 26,250
Interest expense-debt discount 336,269 248,863
Loss on issuance of convertible debt 78,675 356,402
Loss on conversion of convertible debt 154,694
Change in fair value of bifurcated embedded conversion options and derivative warrant liabilities (461,792) (179,808)
Stock-based compensation 20,000 680,487
Changes in operating assets and liabilities:    
Accounts receivable (17,190)
Accounts receivable-related party (5,438)
Other current assets (15,656)
Inventories 23,220
Other assets 8,860
Accounts payable and accrued expenses 54,233 35,284
Accounts payable and accrued expenses, related parties 29,584 (88,572)
Accrued interest on convertible and promissory notes payable 193,333 28,401
Net cash used in operating activities (337,089) (410,533)
Cash Flows from Investing Activities:    
Payments made for note receivable (12,798)
Purchase of notes receivable (345,000) (160,197)
Principal payments received on note receivable 48,333
Net cash used in investing activities (296,667) (172,995)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock 5,000 2,000
Proceeds from issuance of preferred stock 76,900
Advances from related parties 58,366
Payments to related parties (52,584)
Proceeds from issuance of convertible notes 307,000 508,000
Payments of convertible notes payable (32,192)
Proceeds from issuance of notes payable 355,000 21,305
Proceeds from issuance of notes payable, related party 52,745
Payments of notes payable (34,325) (32,050)
Payments of notes payable, related party (19,844)
Net cash provided by financing activities 633,384 581,937
Net change in cash (372) (1,591)
Cash - beginning of the period 405 2,247
Cash - ending of the period 33 656
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 32,207
Supplemental schedule of non-cash investing and financing activities:    
Decrease in accounts payable and accrued expenses-related party in connection with the purchase of a third-party note receivable 25,000
Decrease in notes payable in connection with reduction in note receivable (85,000)
Common stock issued for conversion of debt and accrued interest 183,048 4,518
Decrease in notes payable in connection with common stock issued (7,330)
Decrease in accrued interest in connection with common stock issued $ (21,024)
Issuance of preferred stock to shareholder for payment of accrued expenses, related party 76,900
Warrants issued in connection with notes payable $ 30,987